第一单位：
Departments of Dermatology, Pathology, and Oncology, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA.
作者：
J S,Deutsch [1]
;
R A,Scolyer [2]
;
E,Burton [3]
;
K J,Busam [4]
;
K Y,Chen [5]
;
A,Cimino-Mathews [6]
;
T R,Cottrell [7]
;
C E,de Andrea [8]
;
P O,Fiset [9]
;
G V,Long [10]
;
J,Messina [11]
;
R V,Rawson [12]
;
R,Salgado [13]
;
C M,Schürch [14]
;
R R,Seethala [15]
;
L M,Sholl [16]
;
S,Signoretti [16]
;
S L,Topalian [17]
;
B A,van de Wiel [18]
;
X,Xu [19]
;
J E,Gershenwald [20]
;
M T,Tetzlaff [21]
;
J M,Taube [22]
作者单位：
Departments of Dermatology, Pathology, and Oncology, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA.
[1]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital and NSW Health Pathology, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia.
[2]
The University of Texas MD Anderson Cancer Center, Houston, USA.
[3]
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
[4]
Departments of Dermatology, Johns Hopkins University SOM, Baltimore, USA.
[5]
Pathology, Johns Hopkins University SOM, Baltimore, USA.
[6]
Queen's University Sinclair Cancer Research Institute, Kingston, Canada.
[7]
Pathology, University of Navarra, Pamplona, Spain.
[8]
Department of Pathology, McGill University Health Centre, Montréal, Canada.
[9]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Mater and Royal North Shore Hospitals, Sydney, Australia.
[10]
Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA.
[11]
Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital and NSW Health Pathology, The University of Sydney, Sydney, Australia.
[12]
Department of Pathology, ZAS Hospitals, Antwerp, Belgium; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
[13]
Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
[14]
University of Pittsburgh Medical Center, Department of Pathology, Pittsburgh, USA.
[15]
Department of Pathology, Brigham and Women's Hospital, Boston, USA.
[16]
Department of Surgery, Johns Hopkins University SOM, Baltimore, USA; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA; Johns Hopkins Kimmel Cancer Center, Baltimore, USA.
[17]
Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
[18]
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
[19]
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
[20]
Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, USA.
[21]
Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA; Departments of Dermatology, Pathology, and Oncology, The Mark Foundation Center for Advanced Imaging and Genomics, Baltimore, USA. Electronic address: jtaube1@jhmi.edu.
[22]
DOI
10.1016/j.annonc.2025.10.018
PMID
41469296
发布时间
2026-01-23
换一批
